Dr. Lisa S. Wang
Claim this profilePresbyterian Intercommunity Hospital
Area of expertise
Lung Cancer
Lisa S. Wang has run 8 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Lisa S. Wang has run 7 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
Presbyterian Intercommunity Hospital
PIH Health
Clinical Trials Lisa S. Wang is currently running
Disitamab Vedotin + Pembrolizumab vs Chemotherapy
for Bladder Cancer
This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than platinum-containing chemotherapy to treat patients with UC. This study will also test what side effects happen when participants take these drugs together. A side effect is anything a drug does to the body besides treating the disease. Participants in this study will have cancer that has spread through the body (metastatic) or spread near where it started (locally advanced). In this study, there are 2 different groups. Participants will be assigned to a group randomly. Participants in the disitamab vedotin arm will get the study drug disitamab vedotin once every two weeks and pembrolizumab once every 6 weeks. Participants in the standard of care arm will get gemcitabine once a week for 2 weeks with either cisplatin or carboplatin once every 3 weeks.
Recruiting
2 awards
Phase 3
GLSI-100
for HER2 Positive Breast Cancer
This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk for disease recurrence and have completed both neoadjuvant and postoperative adjuvant standard of care therapy. Treatment consists of 6 intradermal injections, Primary Immunization Series (PIS), over the first 6 months of treatment and 5 booster intradermal injections spaced 6 months apart. A third open-label arm will explore GLSI-100 immunotherapy in non-HLA-A\*02 positive and HER2/neu positive subjects.
Recruiting
1 award
Phase 3
6 criteria
More about Lisa S. Wang
Clinical Trial Related
4 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Lisa S. Wang has experience with
- Pembrolizumab
- Abemaciclib
- Placebo
- Gemcitabine
- Pemetrexed
- Carboplatin
Breakdown of trials Lisa S. Wang has run
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa S. Wang specialize in?
Lisa S. Wang focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Lisa S. Wang currently recruiting for clinical trials?
Yes, Lisa S. Wang is currently recruiting for 3 clinical trials in Whittier California. If you're interested in participating, you should apply.
Are there any treatments that Lisa S. Wang has studied deeply?
Yes, Lisa S. Wang has studied treatments such as Pembrolizumab, Abemaciclib, Placebo.
What is the best way to schedule an appointment with Lisa S. Wang?
Apply for one of the trials that Lisa S. Wang is conducting.
What is the office address of Lisa S. Wang?
The office of Lisa S. Wang is located at: Presbyterian Intercommunity Hospital, Whittier, California 90602 United States. This is the address for their practice at the Presbyterian Intercommunity Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.